Joshi Cherayath

TL;DR: In this paper, a non-invasive method for quantifying diffuse myocardial fibrosis with cardiac magnetic resonance imaging (CMRI) was proposed, which is based on delayed contrast enhancement.

TL;DR: Cardiac magnetic resonance imaging (CMR) is evaluated as a non‐invasive test for cardiac allograft rejection and shows promise in terms of simplicity, accuracy, and reproducibility.

TL;DR: Multi-sequential CMR identifies patients with severe cardiomyopathy who will respond to CRT with a favourable long-term prognosis, and transplant-free survival post-CRT was achieved.

TL;DR: RV delayed enhancement is common in patients with ARVD, whereas detection of fatty infiltration of the right ventricle was rare in the patient population, suggesting the inclusion of RV fibrosis on CMR as a feature of ARVD may improve the diagnostic accuracy of this condition.

TL;DR: In this article, a non-invasive method for quantifying diffuse myocardial fibrosis with cardiac magnetic resonance imaging (CMRI) was proposed, which is based on delayed contrast enhancement.